These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 3389211

  • 21. Intravesical and systemic chemotherapy in the management of superficial bladder cancer.
    Soloway MS.
    Urol Clin North Am; 1984 Nov; 11(4):623-35. PubMed ID: 6438857
    [Abstract] [Full Text] [Related]

  • 22. Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
    Kurth KH, Debruyne FJ, Senge T, Carpentier PJ, Riedl H, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1985 Nov; 185B():135-42. PubMed ID: 3898138
    [No Abstract] [Full Text] [Related]

  • 23. [Prophylaxis of recurrence in superficial bladder carcinoma by intravesical chemotherapy--comparative study between instillation of combined double anticancer agents and single anticancer agent].
    Ikeda R, Chikazawa I, Kobayashi Y, Shiroma K, Nakade T, Suga K, Shiba N, Nakajima C, Moriyama M, Kawamura K, Miyazawa K, Tanaka T, Tsugawa R, Suzuki K, Sato H, Kikuyama A.
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):509-14. PubMed ID: 10097748
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001 Sep; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 32. [Intravesical chemotherapy with 4'-EPI-adriamycin in patients with superficial bladder tumors (randomized study)].
    Tsushima T, Matsumura Y, Ozaki Y, Akagi T, Obama T, Nasu Y, Ohmori H.
    Hinyokika Kiyo; 1985 Dec; 31(12):2215-8. PubMed ID: 3868934
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Photodynamic therapy of superficial cancer of the urinary bladder to prevent relapse].
    Rusakov IG, Sokolov VV, Bystrov AA.
    Vopr Onkol; 2006 Dec; 52(6):675-9. PubMed ID: 17338248
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Stage P-1 primary neoplasia of the bladder. Critical evaluation of results obtained with the use of adriamycin and mitomycin C in the prevention of recurrences].
    Liberti M, Tenaglia R, De Berardinis E, Gentile V.
    Minerva Med; 1984 Feb 28; 75(8):391-4. PubMed ID: 6424059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.